Ernesto GUCCIONE 
                       
    Main Page   Staff Directory   Publications        
                       
   
a filler
  Ernesto GUCCIONE  
  Lab Location: #3-06

email:
eguccione@imcb.a-star.edu.sg
tel:65869844
 
a a a
a a a
  Key Publications  
 


Martinato F, Cesaroni M, Amati B, Guccione E.
Analysis of Myc-induced histone modifications on target chromatin.
PLoS ONE. 2008;3(11):e3650. Epub 2008 Nov 5.

Smith AP, Verrecchia A, Fagŕ G, Doni M, Perna D, Martinato F, Guccione E, Amati B.
Oncogene. 2009 Jan 22;28(3):422-30. Epub 2008 Nov 3.

Guccione E, Bassi C, Casadio F, Martinato F, Cesaroni M, Schuchlautz H, Lüscher B & Amati B.
Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive
Nature. 2007 Oct 18;449(7164):933-7

Guccione E, Martinato F, Finocchiaro G, Luzi L, Tizzoni L, Dall’Olio V, Zardo G, Nervi C, Bernard L and Amati B.
Myc-binding-site recognition in the human genome is determined by chromatin context.
Nature Cell Biology. 2006 Jul;8(7):764-70. Epub 2006 Jun 11

Guccione E, Pim D, Banks L.
HPV-18 E6*I modulates HPV-18 full-length E6 functions in a cell cycle dependent manner.
Int J Cancer. 2004 Jul 20;110(6):928-33.

Guccione E, Lethbridge KJ, Killick N, Leppard KN, Banks L.
HPV E6 proteins interact with specific PML isoforms and allow distinctions to be made between different POD structures.
Oncogene. 2004 Jun 10;23(27):4662-72.

Thomas Laura R, Hepner K, Guccione E, Sawyers C, Lasky L, and Banks L.M,
Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation.
Oncogene. 2002 Aug 1;21(33):5088-96.
IF 6.495

Guccione E>, Massimi P, Bernat A, and Banks L.
Comparative analysis of the intracellular location of the high- and low-risk human papillomavirus oncoproteins.
Virology. 2002 Feb 1;293(1):20-5.

Migliazza A, Bosch F, Komatsu H, Cayanis E, Martinotti S, Toniato E, Guccione E, Qu X, Chien M, Murty VV, Gaidano G, Inghirami G, Zhang P, Fischer S, Kalachikov SM, Russo J, Edelman I, Efstratiadis A, Dalla-Favera R.
Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia.
Blood. 2001 Apr 1;97(7):2098-104.


 
a a a
 
    Ernesto GUCCIONE
 


Ernesto Guccione obtained his Master's degree in Medical Biotechnology in 2000 from Bologna University and his PhD in 2004 from the International Center for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy. He did his postdoctoral work at the European Institute of Oncology (Milan, Italy) where he studied the role of chromatin in defining c-Myc target site recognition. He also identified PRMT6, a member of the Protein Arginine MethylTransferase family, as an important enzyme in controlling transcriptional repression. During his postdoctoral training, he spent four months as an EMBO fellow in the laboratory of J.LaBaer at Harvard Institute of Proteomics. He joined IMCB in 2008 as an Assistant Professor.

       
    Chromatin, Epigenetics and Differentiation
   


Any cell in an organism derives from the same starting genetic material. Functional distinction between cell types is acquired through sequential epigenetic modifications that shape chromatin and in turn affect transcription and cellular state. DNA methylation and Post-translational modifications (PTMs) of histones convey epigenetic information that extends the coding potential of nucleic acids, a phenomenon that has been commonly referred to as “histone code”. PTMs are commonly used to modify protein function. Modifications such as phosphorylation, acetylation and methylation can influence the conformation of the modified protein and its interaction with other proteins or DNA. In the case of histones, PTMs on specific residues can influence chromatin structure and function by modifying the biochemical properties of key amino acids. Histone methylation events, especially on arginine- and lysine-residues, are among the best characterized PTMs, and many of these modifications have been linked to downstream effects. The addition of a methyl group to either residue results in a slight increase in hydrophobicity, in the loss of a potential hydrogen-bond donor site and, in the alteration of the protein interaction surface. Thus far, a number of protein domains have been demonstrated to directly bind to methylated lysine residues. However, the biochemical mechanisms linking histone arginine methylation to downstream biological outputs remain poorly characterized. The work in the lab focuses on the role of histone arginine methylation in transcriptional regulation and on the crosstalk between arginine methylation and other PTMs. We investigate the mechanisms by which differentially methylated arginines on histones modulate transcriptional outcomes and contribute to the complexity of the ‘histone code’.

Histone modification map

     
   

Methylated & unmethylated arginines as protein docking sites: adding another layer of complexity to the ‘histone code’

PTMs are essential for signal transduction. By altering the biophysical features of proteins, they regulate a diverse array of phenomena including protein subcellular localization, protein stability and protein–protein interactions. When a PTM occurs on histones, it directly modifies chromatin structure and contributes to the organization of higher eukaryotic genomes into euchromatic and heterochromatic domains. Euchromatic domains are important for regulating transcription, by ensuring DNA accessibility, the assembly of the transcription machinery and the binding of sequence-specific transcription factors. Conversely, heterochromatic domains maintain the large majority of the genome in a relatively silent and poorly accessible state. Enzymes such as serine/threonine and tyrosine kinases, lysine acetyltransferases, and lysine and arginine methyltransferases are able to phosphorylate acetylate and methylate histones, respectively. Understanding how these enzymes are regulated is of central importance for understanding how gene transcription and genomic integrity are regulated, and for elucidating the mechanisms controlling key physiological and pathological events such as differentiation, development and cancer. A direct effect of PTMs on chromatin is the alteration of its biophysical and biochemical characteristics and the creation of a dynamic platform upon which the transcriptional machinery is recruited and assembled. The histone code hypothesis suggests that histone PTMs can act as binding sites to be interpreted by chromatin readers and effector proteins. Many nuclear proteins contain motifs such as the bromo domain, that selectively interact with acetylated histones. The ‘Royal family’ domains, which are structurally similar to the prototype chromodomain and bind methyl- ated residues, include the Tudor, Plant–Agenet, PWWP and MBT domains. Recently, other domains have been identified as being able to recognize methylated arginines or lysines. One example is the large family of plant homeodomain (PHD) finger-domains, which are present in several chromatin-associated proteins, and have been demonstrated to interact with methylated lysines and arginines on histone tails. Examples of PHD domain-containing proteins include the tumor suppressor inhibitor of growth 2 (ING2), which binds H3K4me3, and Dnmt3a, which has an ATRX–DNMT3–DNMT3L (ADD) domain containing a PHD finger, and specifically binds to H4R3me2s.

Our lab is interested in how arginine methylation specifically contributes to increase the complexity of the histone code. This is achieved
in two main ways:

1.Methylated arginines can act as docking sites for chromatin-binding proteins on histone tails (Figure 1A);

2.Methylated arginines can act as exclusion marks, impeding the binding of proteins to histones (Figure 1B).


   
         
 
(C) Copyright 2012 Institute of Molecular and Cell Biology, A*STAR Singapore.